Analysis of U-47700, a Novel Synthetic Opioid, in Human Urine by LC–MS–MS and LC–QToF

A case of U-47700 overdose with laboratory confirmation and metabolite identification

(2016) Matthew J. Jones et al.   CLINICAL TOXICOLOGY

Two cases of intoxication with new synthetic opioid, U-47700

(2016) K. Domanski et al.   CLINICAL TOXICOLOGY

Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class

(2016) Aaron Schneir et al.   CLINICAL TOXICOLOGY

The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis

(2016) Simon P. Elliott et al.   Drug Testing and Analysis

A case of acute intoxication due to combined use of fentanyl and 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700)

(2016) Vera Coopman et al.   FORENSIC SCIENCE INTERNATIONAL

Two Fatal Intoxications Involving Butyryl Fentanyl

(2016) Justin Poklis et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Quantification of Synthetic Cathinones in Rat Brain Using HILIC–ESI-MS/MS

(2016) Jacob R. Peters et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC–MS-MS and Its Identification in a Drug-Related Death

(2016) Donna Papsun et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC–MS/MS in Postmortem Casework

(2016) Amanda L. A. Mohr et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Mass spectrometric properties ofN-(2-methoxybenzyl)-2-(2,4,6-trimethoxyphenyl)ethanamine (2,4,6-TMPEA-NBOMe), a new representative of designer drugs of NBOMe series and derivatives thereof

(2016) Vadim Shevyrin et al.   JOURNAL OF MASS SPECTROMETRY

Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid–Involved Overdose Deaths — 27 States, 2013–2014

(2016) R. Matthew Gladden et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Analysis of Amphetamine-Derived Designer Drugs by Gas Chromatography with Mass Spectrometry

(2015) Peter Ondra et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

An Acute Acetyl Fentanyl Fatality: A Case Report With Postmortem Concentrations

(2015) Iain M. McIntyre et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Fatal Intoxications Associated with the Designer Opioid AH-7921

(2014) R. Kronstrand et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

A Fatality Involving AH-7921

(2014) Shawn P. Vorce et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Toxicological Findings of Synthetic Cannabinoids in Recreational Users

(2013) R. Kronstrand et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics

(2013) Bjoern Moosmann et al.   JOURNAL OF MASS SPECTROMETRY

Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States

(2011) Henry A. Spiller et al.   CLINICAL TOXICOLOGY

Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples

(2011) Sebastian Dresen et al.   JOURNAL OF MASS SPECTROMETRY

LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum

(2010) Ariane Wohlfarth et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Validation of an LC-MS Method for the Detection and Quantification of BZP and TFMPP and their Hydroxylated Metabolites in Human Plasma and its Application to the Pharmacokinetic Study of TFMPP in Humans*

(2010) Ushtana Antia et al.   JOURNAL OF FORENSIC SCIENCES

Analytical Toxicology of Emerging Drugs of Abuse

(2010) Frank T Peters et al.   THERAPEUTIC DRUG MONITORING